FDA Finds Low Levels Of Cancer-Linked Impurity In Common Heartburn Drugs
The US Food and Drug Administration said on Friday that it has learned that some ranitidine -- acid-reducing and heartburn medicines, including those known by the brand name Zantac -- contain low levels of an impurity that could cause cancer.